Ads
related to: epilepsy seizure disorders
Search results
J&J-backed Rapport Therapeutics valued at $636.8 million in lukewarm debut
Reuters via AOL· 7 hours agoU.S. IPOs are seeing a rebound this year, after an almost two-year dry spell when high interest rates, market volatility and geopolitical turmoil marred investors' risk appetite. Among other ...
Laughter at dog's dramatic reaction to not being allowed to swim
Newsweek· 3 days agoA video of a dog's "sassy" reaction to being banned from swimming has gone viral on TikTok. A large...
Oxtellar XR dosage: Form, strengths, how to take, and more
Medical News Today· 17 hours agoOxtellar XR (oxcarbazepine) is a brand-name drug prescribed to treat focal onset (partial) seizures...
Creativity Not Influenced by Maternal Epilepsy
MedPage Today· 5 days agoPrenatal exposure to high doses of anti-seizure drugs may influence executive function, however
Earnings call: Addex Therapeutics reports on Q1 2024 with mixed results By Investing.com
Investing.com· 1 day agoThe company announced progress in their GABAB positive allosteric modulator program, with a...
Cherokee vote passes: NC's first recreational marijuana market likely in '60-75 days'
Asheville Citizen-Times via Yahoo News· 1 day agoAn anxiety disorder. An autism spectrum disorder. An autoimmune disorder. Anorexia nervosa. Cancer....
Eastern Band of Cherokee set to vote on recreational marijuana; When could sales begin?
Gannett via AOL· 3 days agoAn anxiety disorder. An autism spectrum disorder. An autoimmune disorder. Anorexia nervosa. Cancer....
Onivyde interactions: Other medications, alcohol, and more
Medical News Today· 4 days agoOnivyde has interactions with some other drugs and certain supplements. Examples include certain...
Nutrition and fasting for the brain: Why the keto diet shows promise
Medical Xpress· 3 days agoThe turnout of more than 700 attendees, both live and online, at Eline Dekeyster's lecture on...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoSAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) securities
Ad
related to: epilepsy seizure disorders
